Stock Research for NWBO


Featured Broker: Ally Invest

Get the due diligence for another stock.


NWBO Stock Chart & Research Data

The NWBO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NWBO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


NWBO Due diligence Resources & Stock Charts

The NWBO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NWBO Detailed Price Forecast - CNN Money CNN View NWBO Detailed Summary - Google Finance
Yahoo View NWBO Detailed Summary - Yahoo! Finance Zacks View NWBO Stock Research & Analysis -

Stock Analysis

TradeIdeas View NWBO Trends & Analysis - Trade-Ideas Barrons View NWBO Major Holders - Barrons
NASDAQ View NWBO Call Transcripts - NASDAQ Seeking View NWBO Breaking News & Analysis - Seeking Alpha
Spotlight View NWBO Annual Report - OTC Report View NWBO OTC Short Report -
TradeKing View NWBO Fundamentals - TradeKing Charts View NWBO SEC Filings - Bar Chart
WSJ View Historical Prices for NWBO - The WSJ Morningstar View Performance/Total Return for NWBO - Morningstar
MarketWatch View the Analyst Estimates for NWBO - MarketWatch CNBC View the Earnings History for NWBO - CNBC
StockMarketWatch View the NWBO Earnings - StockMarketWatch MacroAxis View NWBO Buy or Sell Recommendations - MacroAxis
Bullish View the NWBO Bullish Patterns - American Bulls Short Pains View NWBO Short Pain Metrics -

Social Media Mentions

StockTwits View NWBO Stock Mentions - StockTwits PennyStocks View NWBO Stock Mentions - PennyStockTweets
Twitter View NWBO Stock Mentions - Twitter Invest Hub View NWBO Investment Forum News - Investor Hub
Yahoo View NWBO Stock Mentions - Yahoo! Message Board Seeking Alpha View NWBO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for NWBO - Insider Cow View Insider Transactions for NWBO - Insider Cow
CNBC View NWBO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NWBO - OTC Markets
Yahoo View Insider Transactions for NWBO - Yahoo! Finance NASDAQ View Institutional Holdings for NWBO - NASDAQ

Stock Charts

FinViz View NWBO Stock Insight & Charts - StockCharts View NWBO Investment Charts -
BarChart View NWBO Stock Overview & Charts - BarChart Trading View View NWBO User Generated Charts - Trading View

Latest Financial News for NWBO

Northwest Biotherapeutics: 1Q Earnings Snapshot
Posted on Thursday May 17, 2018

The Bethesda, Maryland-based company said it had a loss of 9 cents per share. Losses, adjusted for one-time gains and costs, came to 6 cents per share. The cancer drug developer posted revenue of $132,000 ...

NW Bio Releases Vote Tallies From Special Shareholder Meeting
Posted on Tuesday May 01, 2018

BETHESDA, Md., May 1, 2018 /PRNewswire/ -- Northwest Biotherapeutics (NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today released the vote tallies for the three proposals on the ballot at its Special Meeting of Shareholders held last Friday afternoon in Washington, DC. Proposal 1 was to raise the ceiling on the total number of authorized shares of common stock of the Company from 450 million to 1.2 billion.  For this Proposal, only the common shares could vote.  This Proposal was approved, with Yes votes from 87% of the votes cast (245,267,573), with 4% voting against (11,699,346), and 9% abstaining (25,836,335 votes).  30% did not vote (131,861,943). Proposal 2 was to raise the ceiling on the total number of authorized shares of preferred stock of the Company from 40 million to 100 million.  For this Proposal, both the preferred stock and the common stock could vote.  This Proposal was approved with Yes votes from 86% of the votes cast (327,025,901), with 7% voting against (27,266,121), and 7% abstaining (25,796,199).

NW Bio Announces Additional Funding
Posted on Monday April 30, 2018

On April 26, 2018, the Company and Ms. Powers entered into a note and loan agreement for an additional loan of $1.0 million by Ms. Powers to the Company on the same terms as her prior funding, as previously reported in March.  The Note is convertible into Series B Preferred Stock at $2.30 per share (with each share of Series B Preferred Stock convertible into ten shares of Common Stock at $0.23 per share), and Class D-2 Warrants exercisable for an equal number of shares of Common Stock at $0.30 per share, with warrants on half of the Note repayment amount due and issuable when the loan was provided, and warrants on half of the Note repayment amount due on a proportional basis in the event of conversion of some or all of the Note.

Independent Research on Trending Growth Companies: Northwest Biotherapeutics and Sanuwave Health
Posted on Monday February 26, 2018

NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Northwest Biotherapeutics, Inc. (OTCQB: NWBO) and Sanuwave Health ...

Enter a stock symbol to view the stock details.